Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 13, 2020
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel
Domenica Lorusso, Alessandra Bologna, Sabrina Chiara Cecere, et al.
JNCI Cancer Spectrum
|
October 15, 2025
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer
Alessandra Fabi, Antonio Franco, Laura Cortesi, et al.
Cancers
|
July 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation
Eva-Maria Willing, Claudia Vollbrecht, Christine Vössing, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 31, 2021
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
Raimondo Di Liello, Laura Arenare, Francesco Raspagliesi, et al.
Gynecologic Oncology
|
April 18, 2026
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study
Els Van Nieuwenhuysen, Ignace Vergote, Leslie M Randall, et al.
Lancet (London, England)
|
April 13, 2026
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial
Domenica Lorusso, Laurence Gladieff, David M O'Malley, et al.
Lancet (London, England)
|
June 5, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
Alexander B Olawaiye, Laurence Gladieff, David M O'Malley, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 13, 2020
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel
Domenica Lorusso, Alessandra Bologna, Sabrina Chiara Cecere, et al.
JNCI Cancer Spectrum
|
October 15, 2025
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer
Alessandra Fabi, Antonio Franco, Laura Cortesi, et al.
Cancers
|
July 14, 2023
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation
Eva-Maria Willing, Claudia Vollbrecht, Christine Vössing, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 31, 2021
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial
Raimondo Di Liello, Laura Arenare, Francesco Raspagliesi, et al.
Gynecologic Oncology
|
April 18, 2026
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study
Els Van Nieuwenhuysen, Ignace Vergote, Leslie M Randall, et al.
Lancet (London, England)
|
April 13, 2026
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial
Domenica Lorusso, Laurence Gladieff, David M O'Malley, et al.
Lancet (London, England)
|
June 5, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
Alexander B Olawaiye, Laurence Gladieff, David M O'Malley, et al.
Page
of 11